These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 14983957)
1. The ERSPC Quality Control Committee. Ciatto S BJU Int; 2003 Dec; 92 Suppl 2():57-61. PubMed ID: 14983957 [No Abstract] [Full Text] [Related]
2. Monitoring the ERSPC trial. De Koning HJ; Hakulinen T; Moss SM; Adolfsson J; Smith PH; Alexander FE; BJU Int; 2003 Dec; 92 Suppl 2():112-4. PubMed ID: 14983967 [No Abstract] [Full Text] [Related]
3. Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening. Ciatto S; Zappa M; Villers A; Paez A; Otto SJ; Auvinen A BJU Int; 2003 Dec; 92 Suppl 2():97-100. PubMed ID: 14983964 [No Abstract] [Full Text] [Related]
4. The Data Monitoring Committee--bridging the gap between urology and public health epidemiology. Smith PH BJU Int; 2003 Dec; 92 Suppl 2():55-6. PubMed ID: 14983956 [No Abstract] [Full Text] [Related]
5. Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee. Blijenberg BG; Lilja H; Neels H; Stenman UH BJU Int; 2003 Dec; 92 Suppl 2():66-70. PubMed ID: 14983959 [TBL] [Abstract][Full Text] [Related]
6. Screening for prostate cancer: practical analysis of the ERSPC [corrected] and PLCO trials. Djavan B Eur Urol; 2011 Mar; 59(3):365-9. PubMed ID: 21159418 [No Abstract] [Full Text] [Related]
7. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Schröder FH Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157 [TBL] [Abstract][Full Text] [Related]
8. Branding the ERSPC: a waste or a need? Denis LJ BJU Int; 2003 Dec; 92 Suppl 2():115-6. PubMed ID: 14983968 [No Abstract] [Full Text] [Related]
9. Prostate cancer: to screen or not to screen? Studer UE; Collette L Nat Rev Urol; 2009 Jun; 6(6):299-301. PubMed ID: 19498405 [TBL] [Abstract][Full Text] [Related]
10. ERSPC, PLCO studies and critique of cochrane review 2013. Schröder FH Recent Results Cancer Res; 2014; 202():59-63. PubMed ID: 24531778 [TBL] [Abstract][Full Text] [Related]
11. Do we need the final results of the ERSPC trial? Albers P Eur Urol; 2007 Feb; 51(2):291-2. PubMed ID: 16949198 [No Abstract] [Full Text] [Related]
12. Screening for prostate cancer: reflecting on the quality of evidence from the ERSPC and PLCO studies. Ilic D Recent Results Cancer Res; 2014; 202():65-71. PubMed ID: 24531779 [TBL] [Abstract][Full Text] [Related]
13. European Randomized Study of Screening for Prostate Cancer: achievements and presentation. Roobol MJ; Schröder FH BJU Int; 2003 Dec; 92 Suppl 2():117-22. PubMed ID: 14983969 [No Abstract] [Full Text] [Related]
14. Screening for prostate cancer (PC)--an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Schröder FH Urol Oncol; 2008; 26(5):533-41. PubMed ID: 18774469 [TBL] [Abstract][Full Text] [Related]
15. Prostate cancer screening. Med Lett Drugs Ther; 2008 Nov; 50(1298):85-6. PubMed ID: 18978703 [No Abstract] [Full Text] [Related]
16. The independent statistician for data monitoring committees. DeMets DL; Fleming TR Stat Med; 2004 May; 23(10):1513-7. PubMed ID: 15122729 [TBL] [Abstract][Full Text] [Related]
18. Prostate Cancer Screening - A Perspective on the Current State of the Evidence. Pinsky PF; Prorok PC; Kramer BS N Engl J Med; 2017 Mar; 376(13):1285-1289. PubMed ID: 28355509 [No Abstract] [Full Text] [Related]
19. The NHLBI model: a 25 year history. Friedman L Stat Med; 1993 Mar; 12(5-6):425-31. PubMed ID: 8493421 [TBL] [Abstract][Full Text] [Related]
20. Prostate cancer screening--the evidence, the recommendations, and the clinical implications. Chou R; LeFevre ML JAMA; 2011 Dec; 306(24):2721-2. PubMed ID: 22203543 [No Abstract] [Full Text] [Related] [Next] [New Search]